Investor Stock List
Ranked #3,313 of 8,699 institutional investors

Patient Square Capital LP

Menlo Park, CA

$585M
US stock portfolio at live prices · today −$4.1M (−0.70%)
Live prices, last trade 10:19 AM ET
Value at quarter end (Q3 2026)
$627M
Change from Q2 2026
−$18.8M (−2.92%)
Positions
21 · 6 new, 6 sold out
Filed
Nov 10, 2026

Not counted in the ranking: none$308M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
UTHR 6.00%RVMD 5.55%ARGX 4.50%MIRM 3.91%ABVX 3.03%
StockSharesValue, live% of portfoliovs Q2 2026
UTHR United Therapeutics Corporation62,677$35.1M6.00%Added +69%
RVMD Revolution Medicines, Inc.196,000$32.4M5.55%Reduced −29%
ARGX argenx SE28,000$26.3M4.50%Added +22%
MIRM Mirum Pharmaceuticals, Inc.234,000$22.8M3.91%Reduced −10%
ABVX ABIVAX Société Anonyme243,000$17.7M3.03%Added +18%
BLTE Belite Bio, Inc131,700$17.3M2.96%Added +20%
ONC BeOne Medicines AG33,500$13.3M2.27%Reduced −63%
ZLAB Zai Lab Limited591,510$12.3M2.10%New
DFTX Definium Therapeutics, Inc.385,000$11.2M1.92%New
DBVT DBV Technologies S.A.1,105,606$10.5M1.79%Added +22%
ELVN Enliven Therapeutics, Inc.212,500$10.1M1.72%Unchanged
COGT Cogent Biosciences, Inc.361,927$10.0M1.71%Reduced −15%
KYMR Kymera Therapeutics, Inc.84,000$9.8M1.67%Added +77%
PCVX Vaxcyte, Inc.166,000$9.6M1.64%New
BNTX BioNTech SE105,421$8.6M1.48%Reduced −22%
CMPS COMPASS Pathways plc1,056,269$8.5M1.45%New
RCUS Arcus Biosciences, Inc.410,000$6.7M1.15%Added +15%
HROW Harrow, Inc.145,000$4.6M0.79%New
IVA Inventiva S.A.1,221,225$4.1M0.70%Reduced −38%
ALLO Allogene Therapeutics, Inc.4,550,000$3.0M0.52%Reduced −10%
ZNTL Zentalis Pharmaceuticals, Inc.2,007,485$3.0M0.50%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
ARQT Arcutis Biotherapeutics, Inc.370,000$10.1M
DNTH Dianthus Therapeutics, Inc.108,000$9.1M
XENE Xenon Pharmaceuticals Inc.220,000$8.3M
CCCC C4 Therapeutics, Inc.1,608,815$4.0M
FTH Faeth Therapeutics, Inc.175,050$1.6M
EYPT EyePoint, Inc.720,000$187K